1985
DOI: 10.1148/radiology.156.3.4023247
|View full text |Cite
|
Sign up to set email alerts
|

Malignant melanoma of the eye: treatment of posterior uveal lesions by Co-60 plaque radiotherapy versus enucleation.

Abstract: Survival rates and visual acuity of 100 patients treated for posterior uveal malignant melanoma by cobalt-60 plaque radiotherapy were compared with 150 patients treated by enucleation for the same disease. Life-table comparisons of the entire group showed significant differences in survival rates, with plaque radiotherapy patients appearing to fare better. However, when patients with small or medium tumors were compared, only slight differences were seen, implying that criteria used to select patients for trea… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1988
1988
2003
2003

Publication Types

Select...
4
3

Relationship

0
7

Authors

Journals

citations
Cited by 26 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…In the interval from May 1976 through July 1987, 595 patients have been treated using cobalt-60 plaques, 131 using iodine-I25 plaques, 102 using ruthenium-106 plaques, and 194 using iridium-192 plaques as a joint venture between the Department of Radiation Oncology at Hahnemann University and the Oncology Service of the Wills Eye Hospital in Philadelphia. A recent assessment was undertaken of 243 patients with malignant posterior uveal melanomas treated in a non-randomized concurrent study (27,8). Of these patients, 143 were treated by enucleation and 97 were managed with cobalt-60 plaque therapy.…”
Section: Appropriate Sites For Definitive Radiation Therapymentioning
confidence: 99%
“…In the interval from May 1976 through July 1987, 595 patients have been treated using cobalt-60 plaques, 131 using iodine-I25 plaques, 102 using ruthenium-106 plaques, and 194 using iridium-192 plaques as a joint venture between the Department of Radiation Oncology at Hahnemann University and the Oncology Service of the Wills Eye Hospital in Philadelphia. A recent assessment was undertaken of 243 patients with malignant posterior uveal melanomas treated in a non-randomized concurrent study (27,8). Of these patients, 143 were treated by enucleation and 97 were managed with cobalt-60 plaque therapy.…”
Section: Appropriate Sites For Definitive Radiation Therapymentioning
confidence: 99%
“…Small choroidal melanomas are often treated with episcleral plaque therapy/local resection, while large tumours usually require enucleation. 1,2 …”
Section: Introductionmentioning
confidence: 99%